Logo image of JBS

JBS NV-A (JBS) Stock Analyst Ratings

USA - New York Stock Exchange - NYSE:JBS - NL0015002J37 - Common Stock

13.73 USD
+0.1 (+0.73%)
Last: 11/21/2025, 8:04:00 PM
14.05 USD
+0.32 (+2.33%)
After Hours: 11/21/2025, 8:04:00 PM
Buy % Consensus

81

ChartMill assigns a Buy % Consensus number of 81% to JBS. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 20.49. This target is 49.21% above the current price.
JBS was analyzed by 17 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about JBS.
In the previous month the buy percentage consensus was at a similar level.
JBS was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
JBS Historical Analyst RatingsJBS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -5 -4 -3 -2 -1 0 5 10 15

Price Target & Forecast

Price Low Median Mean High 13.7317.1720.4020.4927.30 - 25.05% 48.58% 49.21% 98.83%
JBS Current Analyst RatingJBS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10
Up and Down Grades
Date Firm Action Rating
2025-10-14 JP Morgan Maintains Overweight -> Overweight
2025-09-03 JP Morgan Maintains Overweight -> Overweight
2025-08-15 Stephens & Co. Reiterate Overweight -> Overweight
2025-06-26 BMO Capital Initiate Outperform
2025-06-26 Stephens & Co. Reiterate Overweight -> Overweight
2025-06-18 B of A Securities Initiate Buy
2025-06-16 Goldman Sachs Initiate Buy

JBS NV-A / JBS FAQ

What do analysts expect the price target to be for JBS NV-A (JBS)?

17 analysts have analysed JBS and the average price target is 20.49 USD. This implies a price increase of 49.21% is expected in the next year compared to the current price of 13.73.


How do analysts rate JBS NV-A (JBS)?

The consensus rating for JBS NV-A (JBS) is 81.1765 / 100 . This indicates that analysts generally have a positive outlook on the stock.